Ryan O'Hare

Pharma company acquires startup Oculeve for $125m (USD), including a novel nasal device for dry eye disease

The number of sight tests carried out in England fell by almost 23,000 in 2014–15, compared with the previous year

The National Institute for Health and Care Excellence has recommended aflibercept and a dexamethasone implant for diabetic macular oedema

A membership organisation for private ophthalmologists has been fined for breaches to competition law, including price setting

Key points for business and health to emerge from summer budget last week (8 July)

New data show median age climbs to 40-years-old as UK population hits 64.6 million people

New market report predicts growth will be driven by the launch of a number of new drugs and fixed-dose combinations

Chancellor announces departmental cuts which will claw back £200m in ‘non-NHS’ savings from the health budget and over £450m from higher and further education

Oraya Therapeutics has received a CE extension for its IRay Radiotherapy treatment for eye cancer patients in the UK, Germany and Switzerland

Ophthalmologists in the UK are ‘leading adopters’ of Oraya Therapy for treating patients with wet AMD